DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 32 filers reported holding PROQR THRAPEUTICS N V in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2015$3,051,000
-12.6%
209,3980.0%0.12%
+1.7%
Q2 2015$3,491,000
-23.8%
209,3980.0%0.12%
-21.6%
Q1 2015$4,582,000
-44.4%
209,398
-44.9%
0.15%
-50.0%
Q4 2014$8,235,000
-9.6%
380,000
-28.3%
0.30%
-10.8%
Q3 2014$9,111,000530,0000.33%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2015
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$3,095,1724.09%
Privium Fund Management B.V. 5,344,446$8,658,0031.82%
DAFNA Capital Management LLC 940,582$1,523,7430.42%
Opaleye Management Inc. 653,000$1,057,8600.25%
Ikarian Capital, LLC 472,625$765,6530.12%
EcoR1 Capital, LLC 2,980,016$4,827,6260.12%
Monaco Asset Management SAM 237,517$384,7780.11%
FRANKLIN STREET ADVISORS INC /NC 150,000$2430.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$5,873,2570.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 189,328$306,7110.01%
View complete list of PROQR THRAPEUTICS N V shareholders